OCULAR THERAPEUTIX, INC (OCUL) Net income 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$265.9MFY2025 · since FY2016: -$44.7M → -$265.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$265.9M | -37.4% |
| FY2024 | -$193.5M | -139.7% |
| FY2023 | -$80.7M | -13.7% |
| FY2022 | -$71.0M | -984.1% |
| FY2021 | -$6.6M | +95.8% |
| FY2020 | -$155.6M | -80.2% |
| FY2019 | -$86.4M | -44.0% |
| FY2018 | -$60.0M | +5.4% |
| FY2017 | -$63.4M | -41.8% |
| FY2016 | -$44.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net marginOCUL Gross profitOCUL Gross marginOCUL Operating incomeOCUL Operating marginOCUL Operating cash flowOCUL Free cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →